Promising Therapies for Treating and/or Preventing Androgenic Alopecia

Kevin J. McElwee, PhD; Jerry Shapiro, MD, FRCPC


Skin Therapy Letter. 2012;17(6) 

In This Article

Hair Loss

Hair loss comes in many forms and it is an increasingly common complaint of dermatology clinic patients. While there are many potential diagnoses, the most frequently encountered are androgenetic alopecia (male pattern baldness [MPB]; female pattern hair loss [FPHL]), telogen effluvium, or alopecia areata. Several forms of scarring alopecia also seem to be becoming more common in dermatology clinics. However by far, the near universal hair loss complaint is androgenetic alopecia (AGA) in men and women. The population frequency of AGA varies with ethnicity, but as a rough generalization up to 70% of men and 40% of women will experience some degree of AGA in their lifetime. While the condition is a widespread experience, negative image perceptions[1] mean affected individuals can be highly motivated to seek diagnosis and treatment.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.